Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV004582675 | SCV005062265 | pathogenic | Tuberous sclerosis 2 | 2023-07-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. The region of the TSC2 gene that includes exon(s) 16 has been determined to be clinically significant (PMID: 16114042, 21520333, 25782670). Therefore, deletions that encompass that region are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with TSC2-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 11-16 of the TSC2 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. |